Touchon J
Service de neurologie B, Hopital Arnaud de Villeneuve, Montpellier.
Encephale. 1995 Dec;21 Spec No 7:41-7.
There is a general tendency to restrict the notion of sleep disorders to insomnia and consequently to limit treatment to the prescription of hypnotics. However, it is very often of benefit to prescribe psychotropic agents, in particular antidepressants, not only in insomnia but also in certain cases of hypersomnia, parasomnia and dysomnia associated with organic diseases. In some conditions, however, antidepressants may either induce or aggravate sleep disorders. This is the case with a number of psychostimulants that occasionally induce insomnia. It is also true of the tricyclic antidepressants, which may worsen or even induce a restlessleg syndrome that is often associated with periodic movement syndrome. On the other hand, the antidepressants may play a therapeutic role in certain sleep disorders : - depression-related insomnia is of course the << primary >> indication for antidepressants. Furthermore, certain antidepressants exhibit a sedative action resulting in a hypnogenic-type effect which appears well before the antidepressant effect; - the other types of insomnia may also often be treated with antidepressants : not acute reactional insomnia, against which hypnotics are remarkably effective, but chronic insomnia. In addition, all antidepressants may eventually correct depressive hypersomnia, but in these cases, it is evidently preferable to prescribe non-sedative drugs. Although some tricyclic antidepressants have been proposed for use in hypersomnia due to sleep apnea, their therapeutic interest is minor compared with mechanical and surgical treatment. In contrast, antidepressants play an important role in the treatment of narcolepsy, particularly for the correction of attacks of cataplexy. Antidepressants have also been used for some time in the treatment of parasomnia related to slow deep sleep (night terrors and sleepwalking), but the antidepressants may also be used in enuresis and in parasomnia related to REM sleep : nightmares, sleep paralysis, behavioral problems associated with REM sleep. Antidepressant (mainly serotoninergic drugs) are often used in the treatment of fibrolitis syndrome. Finally, antidepressants (particularly the serotoninergic antidepressants) play an important role in the drug treatment of fibromyalgia.
人们普遍倾向于将睡眠障碍的概念局限于失眠,因此将治疗局限于开具催眠药。然而,开具精神药物,尤其是抗抑郁药,不仅对失眠有益,而且在某些情况下对与器质性疾病相关的嗜睡症、异态睡眠和睡眠障碍也有益。然而,在某些情况下,抗抑郁药可能会诱发或加重睡眠障碍。一些精神兴奋剂偶尔会诱发失眠就是这种情况。三环类抗抑郁药也是如此,它们可能会使通常与周期性肢体运动综合征相关的不宁腿综合征恶化甚至诱发。另一方面,抗抑郁药可能在某些睡眠障碍中发挥治疗作用:
与抑郁症相关的失眠当然是抗抑郁药的“主要”适应症。此外,某些抗抑郁药具有镇静作用,会产生催眠样效果,这种效果在抗抑郁作用出现之前就很明显;
其他类型的失眠也常常可以用抗抑郁药治疗:不是急性反应性失眠,催眠药对其非常有效,而是慢性失眠。此外,所有抗抑郁药最终都可能纠正抑郁性嗜睡症,但在这些情况下,显然最好开具非镇静药物。虽然一些三环类抗抑郁药已被提议用于治疗睡眠呼吸暂停引起的嗜睡症,但与机械和手术治疗相比,它们的治疗价值较小。相比之下,抗抑郁药在发作性睡病的治疗中起着重要作用,特别是用于纠正猝倒发作。抗抑郁药也已用于治疗与慢波深睡眠相关的异态睡眠(夜惊和梦游)一段时间,但抗抑郁药也可用于治疗遗尿症和与快速眼动睡眠相关的异态睡眠:噩梦、睡眠麻痹、与快速眼动睡眠相关的行为问题。抗抑郁药(主要是5-羟色胺能药物)常用于治疗纤维织炎综合征。最后,抗抑郁药(特别是5-羟色胺能抗抑郁药)在纤维肌痛的药物治疗中起着重要作用。